About this trial
The Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men and women over the age of 18 with ischemic or hemorrhagic stroke seen on imaging and a positive finding for pain in the area(s) affected by their stroke location will be included.
The patients must be at least one month post-stroke but can otherwise enroll at any point.
Disqualifiers
Patients with TIA
Patients with no evidence of stroke on MRI
Patients with implantable devices such as pacemakers, defibrillators, spinal cord stimulators
Patients with history of myocardial infarction in the past 6 months
Trial design
Single group
Treatments tested in this trial
Scrambler Therapy for Post Stroke Pain
DeviceAll participants will either undergo either 5 or 10 treatments using Scrambler Therapy. The number of treatments will be decided by a randomization process.
Treatment groups
Trial outcomes
Primary outcomes
Reduction in post stroke pain
At least a 50% reduction in post stroke pain
Sponsors and contacts
Click on the lead sponsor to view all of their trials.